Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SUITESTENSA

K-Number: K163668 · 2017-06-23

ApplicantEbit Srl
Decision Date2017-06-23
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

SUITESTENSA is the device name listed in this FDA 510(k) record. The listed applicant is Ebit Srl. It received FDA 510(k) clearance on 2017-06-23 under 510(k) number K163668. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SUITESTENSA?

SUITESTENSA is a medical device that received FDA 510(k) clearance on 2017-06-23. The listed applicant is Ebit Srl. The 510(k) number is K163668.

When did SUITESTENSA receive FDA 510(k) clearance?

SUITESTENSA received FDA 510(k) clearance on 2017-06-23, under 510(k) number K163668.

Who is the listed applicant for SUITESTENSA?

The FDA 510(k) record lists Ebit Srl as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SUITESTENSA?

The FDA product code for SUITESTENSA is LLZ.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.